3PC-008 Formulation and stability study of the extemporaneous oral solutions of cardiologic drugs for personalised therapy of newborns

BACKGROUND: If the commercial medicinal products are unavailable on the market, the pharmacist needs to compound a preparation extemporaneously attending to the stability of the active pharmaceutical substance for a labelled time period. This typically occurs when the preparation is targeted at paed...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Sklubalová, Z, Zahálka, L, Matysová, L, Klovrzová, S, Petrželová, M, Horák, P, Kučerová, K, Solich, P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 3: Production and compounding
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535497/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.60
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia